Screener
10x Genomics, Inc. TXG Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$17.93M-152% | -$13.47M+60.8% | -$16.25M+66.9% | -$27.47M+23.2% | $34.54M+191% | ||
| $9.66M+23.7% | $9.96M+24.1% | $10.07M+15.0% | $10.3M+14.9% | $7.82M-12.9% | ||
| $25.62M-7.1% | $22.64M-27.1% | $25.22M-22.5% | $25.26M-24.8% | $27.56M-28.4% | ||
| $16.97M-4.1% | $26.12M-24.0% | $40.78M— | $43.21M+99.7% | $17.71M— | ||
| $1.59M+0.6% | $1.6M-15.6% | $1.78M-34.6% | $687K-82.3% | $1.58M-45.2% | ||
| —— | —— | —— | —— | —— | ||
| -$7.74M-724% | -$1.31M+30.7% | -$1.81M+96.5% | -$8.8M-143% | -$939K-108% | ||
| —— | -$8.42M-2,095% | $2.24M-50.4% | $617K+296% | $3.52M-23.5% | ||
| $12.23M-40.8% | $16.32M-50.5% | $41.26M+176% | $35M+90.9% | $20.65M-14.1% | ||
| $15.39M-4.6% | $24.52M-24.4% | $39M+512% | $42.53M+140% | $16.13M— |
FAQ
- How much cash does 10x Genomics, Inc. generate?
- 10x Genomics, Inc. (TXG) generated $127.1M in operating cash flow over the trailing twelve months.
- What is 10x Genomics, Inc.'s free cash flow?
- After $5.6M of capital expenditures, 10x Genomics, Inc.'s free cash flow was $121.4M over the trailing twelve months, up 113.5% year over year.
- Where does 10x Genomics, Inc.'s cash flow data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
